Hundreds of people with cancer and rare
genetic diseases may still be able to have children thanks to a new statewide fertility
centre, the first of its kind in Australia.
Minister for Health and Medical Research Brad
Hazzard said the Fertility and Research Centre at the Royal Hospital for Women will provide hope to both male and female
patients undergoing cancer treatment that may affect their fertility.
“This centre will
provide first-class fertility preservation services, giving people with a
cancer diagnosis or rare genetic conditions the chance to make their future plans
for children a reality,” Mr Hazzard said.
“This centre is an Australian first, combining the latest research with
fertility preservation and assisted reproduction services in a public hospital
and is part of the NSW Government’s $42 million investment in improving access
to IVF services.”
The Centre will
assist people hoping to have children through IVF, and research will be carried
out on site to help find solutions for those facing obstacles to falling
The NSW Government
is investing $170 million towards additional health services for families as
part of the 2019–20 State Budget.
The Centre, a collaboration between the Royal Hospital for Women and the University of New South
Wales, has an assisted reproduction laboratory and procedure room
where patients can receive a full range of services.
Professor William Ledger, Head of Reproductive Medicine at the Royal
Hospital for Women, said the service will be linked with the Kids Cancer Centre
at Sydney Children’s Hospital.
“Cancer patients diagnosed at Sydney Children’s or Prince of Wales
Hospital can now speak with doctors about fertility preservation the very same
day they are told they need chemotherapy,” Professor Ledger said.
Professor Nicholas Fisk, UNSW Sydney’s Deputy Vice-Chancellor
(Research), said the public centre will conduct significant clinical research.
include new approaches to preserving eggs, ovarian tissue, gametes and embryos
for younger people with cancer, improving IVF success rates and reducing the risk
of implantation failure and miscarriage in women in their 30s and 40s,”
Professor Fisk said.